(E)-1-(4-(Hexyloxy)-3-methylphenyl)-2-(4-(hexyloxy)phenyl)diazene, 95% HPLC, 500mg

5-(4-CHLOROPHENYL)-3,4-DIHYDRO-2H-PYRROLE, 95.0%, 1g

N-(Chloromethyl)phthalimide, 97.0%, 100g

2-isopropyl-1-methyl-1H-imidazole-4-sulfonyl chloride, 95.0%, 1g

2-Amino-7-hydroxy-1,8-naphthyridine, 95.0%, 1g

Copper foil 99.9% 0.25 x 100 x 100 mm 1 pc

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(allyloxy)phenyl)propanoic acid, 98.0%, 25g

Benzyl 2-benzyl-4-oxo-3,4-dihydropyridine-1(2H)-carboxylate, 98+%, 500mg

6,7-Dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxylic acid, 95.0%, 1g

1-(3,5-Difluoropyridin-2-yl)ethanone, 95.0%, 250mg

Triethylene Glycol Butyl Methyl Ether>98.0%(GC)25mL

ASAPIPRANT, 95%, 25mg

Ethyl 6-methoxy-1H-indole-2-carboxylate, 95.0%, 5g